Stock Fundamentals

Company Information

Company Name
Skye Bioscience, Inc. Common Stock
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
ISIN: US83086J2006
CIK: 0001516551
CUSIP: 83086J101
Currency: USD
Full Time Employees: 16
Phone: 858 410 0266
Fiscal Year End: December
IPO Date: Apr 02, 2015
Description:

Skye Bioscience, Inc., a clinical stage biopharmaceutical company, focuses on developing molecules that modulate G protein-coupled receptors (GPCRs) to treat obesity, overweight, and metabolic diseases. Its lead product candidate is nimacimab, a peripherally restricted negative allosteric modulating antibody targeting cannabinoid receptor 1, a key GPCR involved in metabolic regulation. The company was formerly known as Emerald Bioscience, Inc. and changed its name to Skye Bioscience, Inc. in January 2021. The company is headquartered in San Diego, California.

Address:

11250 El Camino Real, San Diego, CA, United States, 92130

Directors & Officers

Name Title Year Born
Mr. Punit S. Dhillon B.A. President, CEO, Principal Accounting Officer & Director 1980
Mr. Tu Diep M.Sc. Chief Operating Officer 1981
Dr. Christopher G. Twitty Ph.D. Chief Scientific Officer 1972
Dr. Puneet S. Arora FACE, M.D., M.S. Chief Medical Officer 1972

Shares Statistics

Shares Outstanding: 32.06M
Shares Float: 20.70M
% Insiders: 133.90%
% Institutions: 4,841.70%
Short % Float: 4.46%

Valuation Metrics

Enterprise Value: $-12.33M
Trailing P/E: 0.00
Forward P/E: 0.00

Financial Highlights

Market Cap: $22.66M
EBITDA: $-57.44M
Book Value: $0.60
Earnings/Share: $-1.30
Profit Margin: 0.00%
Operating Margin: 0.00%
ROA (TTM): -71.93%
ROE (TTM): -126.85%
Revenue (TTM): $0.00
Revenue/Share (TTM): $0.00
Earnings Growth (YOY): 0.00%
Revenue Growth (YOY): 0.00%

Stock Price History

1 Year Price History

2 Years Price History

5 Years Price History

10 Years Price History

Download Financials (Excel)

Financial Charts

Revenue & Net Income (Yearly)

Revenue & Net Income (Quarterly)

Operating Expenses (Yearly)

Operating Expenses (Quarterly)

Balance Sheet (Yearly)

Balance Sheet (Quarterly)

Assets Breakdown (Yearly)

Assets Breakdown (Quarterly)

Liabilities Breakdown (Yearly)

Liabilities Breakdown (Quarterly)

Earnings Per Share (EPS) History

Financial Ratios

Earnings History

Balance Sheet (Yearly)

Financial Ratios

Date Current Ratio Debt/Equity Debt/Assets Interest Coverage Debt/EBITDA
2025-12-31 3.30x 0.01x 0.29x N/A 0.00x
2024-12-31 16.32x 0.00x 0.06x -31.20x -0.01x
2023-12-31 0.84x -2.08x 1.18x -38.33x -0.12x
2022-12-31 0.74x -0.64x 1.33x -27.59x -0.10x
2021-12-31 2.46x 0.35x 0.40x -10.22x -0.27x
2020-12-31 3.38x 3.32x 0.83x -8.90x -0.26x
2019-12-31 2.05x 0.71x 0.73x -6.63x 0.19x
2018-12-31 0.12x -0.09x 8.95x -49.52x -0.29x
2017-12-31 0.69x -0.29x 2.44x -5,785.61x -0.06x
2016-12-31 0.42x 0.00x 5.49x N/A 0.00x
2015-12-31 5.94x 0.00x 0.87x -8.27x 0.00x
2014-12-31 0.38x 0.00x 2.30x N/A 0.00x
2013-12-31 0.58x 0.00x 1.25x -3.37x 0.00x
2012-12-31 8.87x 0.00x 0.10x 6.45x 0.00x

Insider Trading

Date Insider Name Title Transaction Type Shares Price Value
Aug 22, 2025 5Am Partners Vii, Llc N/A Sale 170.45K $3.42 $582.94K
Aug 22, 2025 Andrew J Schwab N/A Sale 170.45K $3.42 $582.94K
Aug 21, 2025 5Am Partners Vii, Llc N/A Sale 60.96K $3.57 $217.61K
Aug 21, 2025 Andrew J Schwab N/A Sale 60.96K $3.57 $217.61K

📦 Raw API Data (JSON Explorer)

Watchlist

0

No stocks in watchlist

Assistant

×
Hello! I'm your AI assistant. I have access to the financial data on this page. Ask me anything about SKYE.US!